Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 9, Number 1—January 2003

Persistence of W135 Neisseria meningitidis Carriage in Returning Hajj Pilgrims: Risk for Early and Late Transmission to Household Contacts

Article Metrics
citations of this article
EID Journal Metrics on Scopus
Annelies Wilder-Smith*1Comments to Author , Timothy M.S. Barkham*2, Sindhu Ravindran*3, Arul Earnest*4, and Nicholas I. Paton*5

Author affiliations: *Tan Tock Seng Hospital, Singapore

Cite This Article


After an outbreak of meningococcal disease caused by Neisseria meningitidis W135, associated with the Hajj pilgrimage in 2001, 15% of returning vaccinated pilgrims carried a single W135 clone, and 55% were still carriers 6 months later. Transmission to 8% of their unvaccinated household contacts occurred within a few weeks, but no late transmission took place. Public health interventions are needed to protect household contacts.

The annual Islamic pilgrimage to Mecca and Medina in Saudi Arabia (Hajj pilgrimage) attracts approximately 2 million pilgrims from all over the world. Overcrowding during the 1-month-long religious rituals may facilitate rapid dissemination of meningococci (13). An international outbreak of meningococcal disease caused by Neisseria meningitidis W135 occurred in association with the Hajj pilgrimage in 2000 and 2001 (4,5), with a high attack rate not only among the pilgrims but also among household contacts of returning pilgrims (610).

Meningococcal carriers are the primary source of N. meningitidis transmission (11). Although vaccination can protect pilgrims against invasive meningococcal disease, it does not prevent acquisition of carriage (12). Pilgrims returning from the Hajj may have a high meningococcal carriage rate (13), and after the W135 outbreak during the Hajj pilgrimage 2001, we documented a high acquisition rate of a single clone of W135 in pilgrims (14). Returning pilgrims may therefore spread the organism to household contacts or even to the community at large.

Although researchers have shown that W135 can attain a high carriage rate (14,15), no data are available on the duration of carriage of W135. Persistence of carriage may represent a threat to the community and has important public health implications. We set out to determine the persistence of W135 meningococcal carriage in pilgrims and to quantify the ongoing risk of transmission to household contacts.


Vaccination records kept at a Moslem center in Singapore were reviewed to identify pilgrims on the Hajj pilgrimage in 2001. Returning pilgrims, all of whom had received pre-Hajj quadrivalent meningococcal polysaccharide vaccine, were contacted and invited to participate in the study.

Tonsillopharyngeal swabs specimens were taken from returning Hajj pilgrims 2 weeks after the Hajj pilgrimage 2001, and those found to be carriers of the W135 clone (henceforth referred to as “pilgrim carriers”) had a repeat swab taken 5–6 months later. Antibiotics were not routinely administered to those who were identified as carriers, although some took antibiotics for other indications during the follow-up.

All household contacts of pilgrim carriers were asked to come for a throat swab within the first month and 5–6 months after the Hajj. In addition, all household contacts whose results of the initial throat swab were negative were asked to return for serial throat swabs taken 2 weeks, 1–2 months, and 2–3 months later.

Swab samples were transferred to a plate of selective culture medium (Oxoid GC, Basingstoke, U.K.). Culture plates were immediately put in candle jars and transferred to the laboratory within 2–4 hours of collection. Serogrouping by latex agglutination (Murex, Dartford, U.K.) and pulsed-field gel electrophoresis (PFGE) was performed on all meningococcal isolates. PFGE was performed by using previously described methods (16). The Tenover criteria were used to interpret the pattern of bands (17).

All subjects gave written informed consent. The study was approved by the Ethics Committee of Tan Tock Seng Hospital.


Swab specimens were taken from 373 Malay pilgrims at a median time of 26 days (range 3–45) after return from the Hajj. The median age was 47 years (range 3–78 years), and 57% were female. Of the 373, a total of 61 (16%) were found to be meningococcal carriers (95% confidence interval [CI] 13% to 21%). Of these 61, 56 (92%) were of a single W135 clone by PFGE. Fifteen percent (95% CI: 12% to 19%) of the returning pilgrims were carriers of the W135 clone (Table). Forty pilgrim carriers returned for a repeat swab at 5–6 months (range 144–182 days) after the Hajj. Of those 40, 22 (55%) remained carriers of the W135 clone.

The household contacts of 42 of the pilgrim carriers (75%) agreed to provide throat swabs specimens. Swabs were taken from 117 (84%) of all existing 139 household contacts at a median time of 32 (range 5–45) days after the Hajj. The median age of household contacts was 14 years (range 1–52 years), and 65.3% were children <18 years of age. Of the 117 contacts, 13 (11%) were meningococcal carriers, and of those carriers 9 (69%) were found to carry the W135 clone (hereafter referred to as “contact carriers”). The 9 contact carriers belonged to eight households, and 11 (19%) of the pilgrim carriers transmitted the W135 clone to at least one household contact.


Thumbnail of Results of serial tonsillopharyngeal swab specimens from returning Hajj pilgrims and their household contacts. A pilgrim carrier is a returning pilgrim with tonsillopharyngeal carriage of the W135 clone; a contact carrier is a household contact of a pilgrim carrier and carries the W135 clone.

Figure. Results of serial tonsillopharyngeal swab specimens from returning Hajj pilgrims and their household contacts. A pilgrim carrier is a returning pilgrim with tonsillopharyngeal carriage of the W135 clone; a contact carrier...

Of the 104 contacts with initially negative results, 26 had a repeat swab specimen taken at a median interval of 15 days (range 11–27 days) after the initial swab within the first month after the Hajj, and all results continued to be negative. Thirty-one of the 104 persons had repeat swabs taken at 1–2 months (median of 39 days, range 30–60), 32 at 2–3 months (median 65 days, range 62–72), and 79 at 5–6 months (median 160 days, range 144–182) after the Hajj, and none was found to have become a carrier (Figure).


The high meningococcal carriage rate in returning pilgrims is consistent with the rate of serogroup A meningococcal infection found in 14% of pilgrims returning to the United States after the 1987 Hajj (13). This rate is also in keeping with studies in other situations in which large numbers of previously unrelated persons have come into close social contact (e.g., university freshmen), and dramatic increases in carriage rate have been shown to occur in the space of just a few days (18,19). However, the carriage rate of 16% in this study is markedly higher than the 2.6% found in pilgrims returning to the United States after the 2001 Hajj (20). This discrepancy is unlikely to be explained by differences in study methodology alone but probably results from differences in living conditions, degree of overcrowding, or social activities during the Hajj. Further detailed epidemiologic studies are warranted to determine exactly which aspect of the pilgrimage is responsible for the high transmission that we have documented. The proportion of overall carriage attributable to this single W135 clone (92% of all carriage) in our study is unusual. Even in the situation of a meningitis outbreak, the proportion of carriage of the hypervirulent strain responsible for invasive disease rarely exceeds the overall proportion of carriage in the population by a few percentage points (11,21,22).

In addition to our findings that W135 can attain a high carriage rate, we have shown that duration of carriage with this strain is lengthy (55% of carriers remain positive after 5–6 months). This longevity indicates that returning pilgrims may represent an ongoing threat to the community.

To our knowledge, this study is the first to investigate the extent of early transmission of N. meningitidis from pilgrim carriers to household contacts. We found that returning pilgrims carrying the W135 clone transmitted it to 7.7% of their household contacts, which is of the same order of magnitude as the transmission rate of meningococcal carriage from patients with invasive disease to household contacts (23,24). However, acquisition occurred only in the first month of contact with the returning pilgrim carriers, and none of the contacts with initially negative results acquired the strain after months of exposure. The absence of late transmission is an important new finding for which the explanation is currently unclear. Possibilities include the absence of particular epidemiologic risk factors for transmission in contacts with persistently negative results, host protective factors, or the attenuated virulence of the organism in the pilgrim carrier over time. Further studies are warranted to investigate our findings.

The absence of late transmission in our cohort is also consistent with our national epidemiologic data, which showed that all the cases of invasive W135 meningococcal disease in contacts of returning Hajj pilgrims occurred within 2 months after the end of the Hajj pilgrimage 2001 and no further cases occurred later in the year (10,25). However, although persistence of carriage appears not to put the household contact at risk, this persistence may be an important threat to the community at large. Cases of W135 disease were identified in the United Kingdom several months after the end of the Hajj, but most of these case-patients had no identifiable direct contact with Hajj pilgrims (26).

Although vaccination may protect the pilgrims from invasive disease, our data show that returning pilgrims represent a sizeable reservoir of a highly transmissible and persistent W135 clone, which places their unvaccinated family contacts (and possibly the community at large) at risk of invasive disease. The appropriate public health response to this problem is unclear. One approach would be to eradicate carriage in pilgrims by administering antibiotics at the point of return to their home countries. However, more data on the impact of this intervention and on resistance and safety issues are needed before embarking on such a large-scale program. Vaccination of household contacts is a potential strategy, but it would be expensive and difficult to implement. Increasing the uptake of the quadrivalent meningococcal vaccine (now mandatory for all pilgrims) may have a beneficial effect in decreasing the carriage of W135 (6). Although the vaccine did not prevent acquisition of carriage in our cohort of Singaporean pilgrims, it may have a greater effect when the entire Hajj pilgrim population is vaccinated. Future studies are essental in order to determine the public health impact of such a vaccination program.

A.W.S. originated the study idea and was responsible for study design, data collection, analysis, and interpretation; she also wrote the final manuscript.

T.B. was responsible for the meningococcal cultures, serogrouping, and pulsed-field gel electrophoresis, and contributed to the manuscript.

S.R. performed pulsed-field gel electrophoresis and contributed to the manuscript.

A.E. was responsible for data entry and statistical analysis. N.P. contributed to the study design and data interpretation, and co-wrote the final manuscript.



We thank the research nurses Fatimah Karim, Anushia Panchalingham, and Fauziah Aziz for taking throat swabs; Bernard Peperstraete for helping with the logistics; and Richard Bellamy for valuable comments on earlier drafts of this paper. Finally, we thank all the Hajj pilgrims and their household contacts for participating in this study.

The study was funded by the National Medical Research Council of Singapore.



  1. al-Gahtani  YM, el Bushra  HE, al-Qarawi  SM, al-Zubaidi  AA, Fontaine  RE. Epidemiological investigation of an outbreak of meningococcal meningitis in Makkah (Mecca), Saudi Arabia, 1992. Epidemiol Infect. 1995;115:399409. DOIPubMedGoogle Scholar
  2. Novelli  VM, Lewis  RG, Dawood  ST. Epidemic group A meningococcal disease in Haj pilgrims. Lancet. 1987;2:863. DOIPubMedGoogle Scholar
  3. Moore  PS, Reeves  MW, Schwartz  B, Gellin  BG, Broome  CV. Intercontinental spread of an epidemic group A Neisseria meningitidis strain. Lancet. 1989;2:2603. DOIPubMedGoogle Scholar
  4. Taha  MK, Achtman  M, Alonso  JM, Greenwood  B, Ramsay  M, Fox  A, Serogroup W135 meningococcal disease in Hajj pilgrims. Lancet. 2000;356:2159. DOIPubMedGoogle Scholar
  5. Meningococcal disease, serogroup W135. Wkly Epidemiol Rec. 2001;76:1412.PubMedGoogle Scholar
  6. Hahne  SJM, Gray  SJ, Aguilera  JF, Crowcroft  NS, Nichols  T, Kacymarski  EB, W135 meningococcal disease in England and Wales associated with Hajj 2000 and 2001. Lancet. 2002;359:5823. DOIPubMedGoogle Scholar
  7. Issack  MI, Ragavoodoo  C. Hajj-related Neisseria meningitidis serogroup w135 in Mauritius. Emerg Infect Dis. 2002;8:3324. DOIPubMedGoogle Scholar
  8. Aguilera  JF, Perrocheau  A, Meffre  C, Hahne  S. Outbreak of serogroup w135 meningococcal disease after the Hajj pilgrimage, Europe, 2000. Emerg Infect Dis. 2002;8:7617.PubMedGoogle Scholar
  9. Fonkoua  MC, Taha  MK, Nicolas  P, Cunin  P, Alonso  JM, Bercion  R, Recent increase in meningitis caused by Neisseria meningitidis serogroups A and W135, Yaounde, Cameroon. Emerg Infect Dis. 2002;8:3279. DOIPubMedGoogle Scholar
  10. Wilder-Smith  A, Goh  KT, Barkham  T, Paton  N. Virulence of the Hajj associated W135 outbreak strain: estimates of attack rate in a defined population and the risk of developing invasive disease in carriers. [Q8: update?]. Clin Infect Dis. In press.
  11. Stephens  DS. Uncloaking the meningococcus: dynamics of carriage and disease. Lancet. 1999;353:9412. DOIPubMedGoogle Scholar
  12. Rosenstein  NE, Perkins  BA, Stephens  DS, Popovic  T, Hughes  JM. Meningococcal disease. N Engl J Med. 2001;344:137888. DOIPubMedGoogle Scholar
  13. Moore  PS, Harrison  LH, Telzak  EE, Ajello  GW, Broome  CV. Group A meningococcal carriage in travelers returning from Saudi Arabia. JAMA. 1988;260:26869. DOIPubMedGoogle Scholar
  14. Wilder-Smith  A, Barkham  TMS, Earnest  A, Paton  NI. Acquisition of meningococcal carriage in Hajj pilgrims and transmission to their household contacts: prospective study. BMJ. 2002;325:3656. DOIPubMedGoogle Scholar
  15. MacLennan  JM, Urwin  R, Obaro  S, Griffiths  D, Greenwood  B, Maiden  MC. Carriage of serogroup W-135, ET-37 meningococci in The Gambia: implications for immunisation policy? Lancet. 2000;356:1078. DOIPubMedGoogle Scholar
  16. Bevanger  L, Bergh  K, Gisnas  G, Caugant  DA, Froholm  LO. Identification of nasopharyngeal carriage of an outbreak strain of Neisseria meningitidis by pulsed-field gel electrophoresis versus phenotypic methods. J Med Microbiol. 1998;47:9938. DOIPubMedGoogle Scholar
  17. Tenover  FC, Arbeit  RD, Goering  RV, Mickelsen  PA, Murray  BE, Persing  DH, Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33:22339.PubMedGoogle Scholar
  18. Ala’Aldeen  DA, Neal  KR, Ait-Tahar  K, Nguyen-Van-Tam  JS, English  A, Falla  TJ, et al. Dynamics of meningococcal long-term carriage among university students and their implications for mass vaccination. J Clin Microbiol. 2000;38:23116.PubMedGoogle Scholar
  19. Neal  KR, Nguyen-Van-Tam  JS, Jeffrey  N, Slack  RC, Madeley  RJ, Ait-Tahar  K, Changing carriage rate of Neisseria meningitidis among university students during the first week of term: cross sectional study. BMJ. 2000;320:8469. DOIPubMedGoogle Scholar
  20. Centers for Disease Control and Prevention. Update: assessment of risk for meningococcal disease associated with the Hajj 2001. MMWR Morb Mortal Wkly Rep. 2001;50:2212.PubMedGoogle Scholar
  21. Caugant  DA, Kristiansen  BE, Froholm  LO, Bovre  K, Selander  RK. Clonal diversity of Neisseria meningitidis from a population of asymptomatic carriers. Infect Immun. 1988;56:20608.PubMedGoogle Scholar
  22. Conyn-van Spaendonck  MA, Reintjes  R, Spanjaard  L, van Kregten  E, Kraaijeveld  AG, Jacobs  PH. Meningococcal carriage in relation to an outbreak of invasive disease due to Neisseria meningitidis serogroup C in the Netherlands. J Infect. 1999;39:428. DOIPubMedGoogle Scholar
  23. Farries  JS, Dickson  W, Greenwood  E, Malhotra  TR, Abbott  JD, Jones  DM. Meningococcal infections in Bolton, 1971–74. Lancet. 1975;2:11820. DOIPubMedGoogle Scholar
  24. Simmons  G, Martin  D, Stewart  J, Jones  N, Calder  L, Bremner  D. Carriage of Neisseria meningitidis among household contacts of patients with meningococcal disease in New Zealand. Eur J Clin Microbiol Infect Dis. 2001;20:23742.PubMedGoogle Scholar
  25. Meningococcal disease caused by N. meningitidis serogroup W135. Epidemiological News Bulletin Singapore. 2001;27:556.
  26. Wilder-Smith  A, Barkham  TMS, Paton  NI. Sustained outbreak of W135 meningococcal disease in east London, UK. Lancet. 2002;360:6445. DOIPubMedGoogle Scholar




Cite This Article

DOI: 10.3201/eid0901.020131

1Originated the study idea; was responsible for study design, data collection, analysis, and interpretation; and wrote the final manuscript.

2Was responsible for the meningococcal cultures, serogrouping, and pulsed-field gel electrophoresis (PFGE), and contributed to the manuscript.

3Performed PFGE and made other contributions to the manuscript.

4Was responsible for data entry and statistical analysis.

5Contributed to the study design and data interpretation, and co-wrote the final manuscript.

Table of Contents – Volume 9, Number 1—January 2003

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.



Please use the form below to submit correspondence to the authors or contact them at the following address:

Annelies Wilder-Smith, Head, Travellers’ Health and Vaccination Centre, Department of Infectious Diseases, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Singapore 308433; fax (65) 6252 4056

Send To

10000 character(s) remaining.


Page created: December 07, 2010
Page updated: December 07, 2010
Page reviewed: December 07, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.